{
  "report_rows": [
    {
      "kpi": "Revenue",
      "prediction": "BEAT",
      "answer": "pred ~$2.620B vs. cons $2.590B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$1.392B vs. cons $1.369B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "AFFO per diluted share",
      "prediction": "BEAT",
      "answer": "pred ~$11.40 vs. cons $11.25",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Revenue",
      "prediction": "LOWER",
      "answer": "guide ~$2.570B vs. cons $2.582B (2026Q3)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue",
      "prediction": "UNCHANGED",
      "answer": "guide ~$10.240B vs. cons $10.239B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EBITDA",
      "prediction": "UNCHANGED",
      "answer": "guide ~$5.240B vs. cons $5.230B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "AFFO per diluted share",
      "prediction": "UNCHANGED",
      "answer": "guide ~$43.05 vs. cons $43.05 (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -2.2,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -4.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "The Q2 AFFO/share beat of ~$11.40 vs. $11.25 consensus is Hampton-heavy, while FY2026 guidance of ~$43.05 vs. $43.05 consensus implies only ~$20.86 for 2H26 versus the prior Street-implied ~$21.01. That modest out-period cut, a ~$2.570B Q3 revenue guide versus $2.582B consensus, and elevated valuation should drive negative estimate revisions after the headline beat.",
  "day5_confidence": "MEDIUM"
}